You are here: Industry Insights > Ferring

News List

Sun Pharma, Ferring Pharmaceuticals sign licensing agreement to launch CARITEC in India expresspharma
June 03, 2021
Sun Pharmaceutical Industries announced that one of its wholly owned subsidiaries has entered into a license agreement with Ferring Pharmaceuticals, a subsidiary of Switzerland-based biopharmaceuticals MNC Ferring Pharmaceuticals, to commercialise a ...
Ferring Recalls DDAVP Nasal Spray, Desmopressin Acetate Nasal Spray, STIMATE Nasal Spray americanpharmaceuticalreview
August 07, 2020
Ferring Pharmaceuticals US is voluntarily recalling all lots on the market of DDAVP® Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE® Nasal Spray 1.5 mg/mL to the consumer level.
Ferring spinout FerGene nabs Ipsen's David Meek as CEO firstwordpharma
December 18, 2019
Ipsen announced Wednesday that CEO David Meek has resigned from his position and will assume the chief executive role at FerGene, a new gene therapy company recently launched by Ferring Pharmaceuticals and Blackstone Life Sciences, effective January 14 ne
Ferring, Rebiotix and Karolinska Institutet Extend Collaboration to Research Next Generation of Microbiome Treatments pharmafocusasia
January 24, 2019
Ferring Pharmaceuticals and Karolinska Institutet announced today a five-year extension of their collaboration to explore the potential of the human microbiome in reproductive medicine and women’s health and gastroenterology....
Ferring Acquires Rebiotix americanpharmaceuticalreview
April 09, 2018
Ferring Pharmaceuticals and Rebiotix announce they have agreed to the acquisition of Rebiotix by Ferring.
Ferring acquires Rebiotix Inc. biospectrumasia
April 08, 2018
The most advanced investigational microbiome treatment from Rebiotix is RBX2660, a non-antibiotic treatment currently in Phase 3 development for the prevention of recurrent CDI
Ferring Buys Rebiotix: Acquires Phase III Non-Antibiotic Treatment biospace
April 08, 2018
Ferring Pharmaceuticals, headquartered in Saint-Prex, Swizerland, is acquiring Roseville, Minnesota’s Rebiotix. Financial details have not been disclosed.
Ferring's ZOMACTON (somatropin) for Injection Receives FDA Approval to Treat Growth Hormone Deficien biospace
February 02, 2018
Ferring Pharmaceuticals today announced thatFDA has approved ZOMACTON® for Injection 5 mg and 10 mg recombinant human growth hormone indicated for replacement of GH in adults with GH deficiency.
Ferring Appoints EVP, CPO, and New Executive Board Member americanpharmaceuticalreview
July 04, 2017
Ferring Pharmaceuticals announced today that Lars Peter Brunse has been appointed Executive Vice President and Chief Production Officer, and made a member of the Ferring Executive Board, effective immediately.
Ferring backs Foresee's SIF platform for controlled-release formulations cphi-online
February 15, 2017
Foresee technology can help to develop stable, formulated peptides in solution for controlled-release therapy for 3- and 6-month durations of action after a single injection.